Inhibition of the intrinsic factor X activating complex by protein S: Evidence for a specific binding of protein S to factor VIII

88Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Protein S is a vitamin K-dependent nonenzymatic anticoagulant protein that acts as a cofactor to activated protein C. Recently it was shown that protein S inhibits the prothrombinase reaction independent of activated protein C. In this study, we show that protein S can also inhibit the intrinsic factor X activation via a specific interaction with factor VIII. In the presence of endothelial cells, the intrinsic activation of factor X was inhibited by protein S with an IC50 value of 0.28 ± 0.04 μmol/L corresponding to the plasma concentration of protein S. This inhibitory effect was even more pronounced when the intrinsic factor X activation was studied in the presence of activated platelets (IC50 = 0.15 ± 0.02 μmol/L). When a nonlimiting concentration of phospholipid vesicles was used, the plasma concentration of protein S (300 nmol/L) inhibited the intrinsic factor X activation by 40%. Thrombin-cleaved protein S inhibited the endothelial cell-mediated factor X activation with an IC50 similar to that of native protein S (0.26 ± 0.02 μmol/L). Protein S in complex with C4b-binding protein inhibited the endothelial cell-mediated factor X activation more potently than protein S alone (IC50 = 0.19 ± 0.03 μmol/L). Using thrombin activated factor VIII, IC50 values of 0.53 ± 0.09 μmol/L and 0.46 ± 0.10 μmol/L were found for native protein S and thrombin-cleaved protein S, respectively. The possible interactions of protein S with factor IXa, phospholipids, and factor VIII were investigated. The enzymatic activity of factor IXa was not affected by protein S, and interaction of protein S with the phospholipid surface could not fully explain the inhibitory effect of protein S on the factor X activation. Using a solid-phase binding assay, we showed a specific, saturable, and reversible binding of protein S to factor VIII with a high affinity. The concentration of protein S where half-maximal binding was reached (B1/2max) was 0.41 ± 0.06 μmol/L. A similar affinity was found for the interaction of thrombin-cleaved protein S with factor VIII (B1/2max = 0.40 ± 0.04 μmol/L). The affinity of the complex of protein S with C4B-binding protein appeared to be five times higher (B1/2max = 0.07 ± 0.03 μmol/L). Because the affinities of the interaction of the different forms of protein S with factor VIII correspond to the IC50 values observed for the intrinsic factor X activating complex, the interaction of protein S with factor VIII may explain the inhibitory effect of protein S on the intrinsic factor X activating complex. These data suggest that protein S exerts an activated protein C independent anticoagulant function, not only by inhibiting the prothrombinase reaction, but also by inhibiting the intrinsic activation of factor X. © 1995 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Koppelman, S. J., Hackeng, T. M., Sixma, J. J., & Bouma, B. N. (1995). Inhibition of the intrinsic factor X activating complex by protein S: Evidence for a specific binding of protein S to factor VIII. Blood, 86(3), 1062–1071. https://doi.org/10.1182/blood.v86.3.1062.bloodjournal8631062

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free